Wellington Management focuses on investment management by applying its full resources to meet the needs of institutional clients they serve.
Wellington Management focuses on investment management. The company applies its full resources to meet the needs of the institutional clients they serve. Their investment approaches span the global equity, fixed income, currency, commodity, and alternatives markets. They also offer asset allocation, multi-manager, and specialty approaches. It was founded in 1928 and headquartered in Boston, Massachusetts.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 7, 2022
Apogee Therapeutics
|
Series B | $149M | Biotechnology | — |
Dec 5, 2022
ROKT
|
Secondary Market | — | B2B | Yes |
Nov 14, 2022
MBX Biosciences
|
Series B | $115M | Biotechnology | Yes |
Aug 31, 2022
SeatGeek
|
Series E | $238M | Ediscovery | — |
Jul 21, 2022
Meati
|
Series C | $150M | Consumer Goods | — |